Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Universitätsklinik für Innere Medizin

Klinische Abteilung für Onkologie

SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |

** = Publikationen gelistet in SCI/SSCI/Pubmed

Originalarbeit (Zeitschrift)

** Aigner, B; Kornprat, P; Schöllnast, H; Kasparek, AK; Mischinger, HJ; Haybaeck, J A Case of Focal Small-cell Neuroendocrine Carcinoma in the Vicinity of the Extrahepatic Bile Duct, Adjacent to an Extensive Biliary Intraepithelial Neoplasm: A Diagnostic Challenge with Major Clinical Implications.
Anticancer Res. 2015; 35(9):4821-4828 (- Case Report)
Web of Science PubMed

 

** Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach.
Clin Chem. 2015; 61(6):838-849 Doi: 10.1373/clinchem.2014.234286 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Bezan, A; Mrsic, E; Krieger, D; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
J Urol. 2015; 194(1):30-35 Doi: 10.1016/j.juro.2015.01.083
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Pichler, M; Mrsic, E; Reitz, D; Krieger, D; Venturino, L; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
J Clin Pathol. 2015; 68(7):547-551 Doi: 10.1136/jclinpath-2014-202683
Web of Science PubMed FullText FullText_MUG

 

** Fitzal, F; Filipits, M; Rudas, M; Greil, R; Dietze, O; Samonigg, H; Lax, S; Herz, W; Dubsky, P; Bartsch, R; Kronenwett, R; Gnant, M The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
Br J Cancer. 2015; 112(8):1405-1410 Doi: 10.1038/bjc.2015.98 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Gary, T; Pichler, M; Schilcher, G; Hafner, F; Hackl, G; Rief, P; Eller, P; Brodmann, M Elevated Blood Urea Nitrogen is Associated With Critical Limb Ischemia in Peripheral Arterial Disease Patients.
Medicine (Baltimore). 2015; 94(24):e948-e948 Doi: 10.1097/MD.0000000000000948 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Knauer, M; Moik, M; Jakesz, R; Seifert, M; Taucher, S; Bjelic-Radisic, V; Balic, M; Eidtmann, H; Eiermann, W; Steger, G; Kwasny, W; Dubsky, P; Selim, U; Fitzal, F; Hochreiner, G; Wette, V; Sevelda, P; Ploner, F; Bartsch, R; Fesl, C; Greil, R; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
Ann Oncol. 2015; 26(2):313-320 Doi: 10.1093/annonc/mdu544 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF; Austrian Breast and Colorectal Cancer Study Group Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
LANCET. 2015; 386(9992): 433-443. Doi: 10.1016/S0140-6736(15)60995-3
Web of Science PubMed FullText FullText_MUG

 

** Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M; Jakesz, R; Ferree, S; Cowens, JW; Nielsen, T; Schaper, C; Fesl, C; Cuzick, J Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Ann Oncol. 2015; 26(8):1685-1691 Doi: 10.1093/annonc/mdv215 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Grassi, L; Berardi, MA; Ruffilli, F; Meggiolaro, E; Andritsch, E; Sirgo, A; Caruso, R; Juan Linares, E; Bellé, M; Massarenti, S; Nanni, MG; IOR-IRST Psycho-Oncology and UniFE Psychiatry Co-Authors Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study.
Psychother Psychosom. 2015; 84(6):339-347 Doi: 10.1159/000431256 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Krieger, D; Mrsic, E; Pohlmann, K; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.
Anticancer Res. 2015; 35(6):3463-3469
Web of Science PubMed

 

** Hutterer, GC; Sobolev, N; Ehrlich, GC; Gutschi, T; Stojakovic, T; Mannweiler, S; Pummer, K; Zigeuner, R; Pichler, M; Dalpiaz, O Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.
J Clin Pathol. 2015; 68(5):351-355 Doi: 10.1136/jclinpath-2014-202658
Web of Science PubMed FullText FullText_MUG

 

** Kandioler, D; Mittlböck, M; Kappel, S; Puhalla, H; Herbst, F; Langner, C; Wolf, B; Tschmelitsch, J; Schippinger, W; Steger, G; Hofbauer, F; Samonigg, H; Gnant, M; Teleky, B; Kührer, I; p53 Research Group and the Austrian Breast and Colorectal Study Group (ABCSG) TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.
EBioMedicine. 2015; 2(8):825-830 Doi: 10.1016/j.ebiom.2015.06.003 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.
Breast. 2015; 24(5):667-672 Doi: 10.1016/j.breast.2015.08.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Langsenlehner, T; Pichler, M; Thurner, EM; Krenn-Pilko, S; Stojakovic, T; Gerger, A; Langsenlehner, U Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy.
Urol Oncol. 2015; 33(5): 201.e9-201201. Doi: 10.1016/j.urolonc.2015.02.002
PubMed FullText FullText_MUG

 

** Langsenlehner, T; Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Gerger, A; Pichler, M Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.
World J Urol. 2015; 33(11):1661-1667 Doi: 10.1007/s00345-015-1494-7
Web of Science PubMed FullText FullText_MUG

 

** Langsenlehner, U; Hofmann, G; Renner, W; Gerger, A; Krenn-Pilko, S; Thurner, EM; Krippl, P; Langsenlehner, T Association of vascular endothelial growth factor - A gene polymorphisms and haplotypes with breast cancer metastases.
Acta Oncol. 2015; 54(3): 368-376. Doi: 10.3109/0284186X.2014.948056 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Li, C; Rezania, S; Kammerer, S; Sokolowski, A; Devaney, T; Gorischek, A; Jahn, S; Hackl, H; Groschner, K; Windpassinger, C; Malle, E; Bauernhofer, T; Schreibmayer, W Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line.
Sci Rep. 2015; 5(2):8364-8364 Doi: 10.1038/srep08364 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mayr, C; Wagner, A; Stoecklinger, A; Jakab, M; Illig, R; Berr, F; Pichler, M; Di Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T 3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract Cancer.
Anticancer Res. 2015; 35(9):4697-4705
Web of Science PubMed

 

** Reitz, D; Gerger, A; Seidel, J; Kornprat, P; Samonigg, H; Stotz, M; Szkandera, J; Pichler, M Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer.
J Clin Pathol. 2015; 68(6):427-433 Doi: 10.1136/jclinpath-2014-202451
Web of Science PubMed FullText FullText_MUG

 

** Ress, AL; Perakis, S; Pichler, M microRNAs and Colorectal Cancer.
Adv Exp Med Biol. 2015; 889(6):89-103 Doi: 10.1007/978-3-319-23730-5_6
Web of Science PubMed FullText FullText_MUG

 

** Ress, AL; Stiegelbauer, V; Winter, E; Schwarzenbacher, D; Kiesslich, T; Lax, S; Jahn, S; Deutsch, A; Bauernhofer, T; Ling, H; Samonigg, H; Gerger, A; Hoefler, G; Pichler, M MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.
Mol Carcinog. 2015; 54(11):1442-1450 Doi: 10.1002/mc.22218
Web of Science PubMed FullText FullText_MUG

 

** Ress, AL; Wagle, R; Pichler, M Multi-omics in prognosis of hepatocellular carcinoma.
Ann Transl Med. 2015; 3(1):2-2 Doi: 10.3978/j.issn.2305-5839.2014.12.07 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schwarzenbacher, D; Stiegelbauer, V; Deutsch, A; Ress, AL; Aigelsreiter, A; Schauer, S; Wagner, K; Langsenlehner, T; Resel, M; Gerger, A; Ling, H; Ivan, C; Calin, GA; Hoefler, G; Rinner, B; Pichler, M Low spinophilin expression enhances aggressive biological behavior of breast cancer.
Oncotarget. 2015; 6(13):11191-11202 Doi: 10.18632/oncotarget.3586 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Sebio, A; Gerger, A; Matsusaka, S; Yang, D; Zhang, W; Stremitzer, S; Stintzing, S; Sunakawa, Y; Yamauchi, S; Ning, Y; Fujimoto, Y; Ueno, M; Lenz, HJ Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer.
Pharmacogenet Genomics. 2015; 25(1):30-37 Doi: 10.1097/FPC.0000000000000101 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stotz, M; Szkandera, J; Stojakovic, T; Seidel, J; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Seggewies, F; Hoefler, G; Gerger, A; Pichler, M The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
Clin Chem Lab Med. 2015; 53(3):499-506 Doi: 10.1515/cclm-2014-0447
Web of Science PubMed FullText FullText_MUG

 

** Suppan, C; Bjelic-Radisic, V; La Garde, M; Groselj-Strele, A; Eberhard, K; Samonigg, H; Loibner, H; Dandachi, N; Balic, M Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy.
BMC Cancer. 2015; 15:1027-1027 Doi: 10.1186/s12885-015-2005-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Friesenbichler, J; Stojakovic, T; Leithner, A; Pichler, M The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients.
Am J Surg. 2015; 210(1): 111-116. Doi: 10.1016/j.amjsurg.2014.10.021
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Gary, T; Leithner, A; Pichler, M Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients.
Clin Chem Lab Med. 2015; 53(3):493-497 Doi: 10.1515/cclm-2014-0486
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Herzog, S; Pichler, M; Stiegelbauer, V; Stotz, M; Schaberl-Moser, R; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Renner, W; Lenz, HJ; Berghold, A; Gerger, A LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
Pharmacogenomics J. 2015; 15(5):391-396 Doi: 10.1038/tpj.2015.2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.
World J Urol. 2015; 33(10):1467-1473 Doi: 10.1007/s00345-014-1459-2
Web of Science PubMed FullText FullText_MUG

 

** Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Eur J Cancer. 2015; 51(5):610-619 Doi: 10.1016/j.ejca.2015.01.002
Web of Science PubMed FullText FullText_MUG

 

** Troppan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, GG; Beham-Schmid, C; Neumeister, P; Deutsch, A miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Int J Mol Sci. 2015; 16(8):18077-18095 Doi: 10.3390/ijms160818077 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Troppan, KT; Melchardt, T; Deutsch, A; Schlick, K; Stojakovic, T; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Egle, A; Pichler, M The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Eur J Haematol. 2015; 95(6):538-544 Doi: 10.1111/ejh.12529
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Bochis, OV; Irimie, A; Pichler, M; Berindan-Neagoe, I The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
J Gastrointestin Liver Dis. 2015; 24(2):225-234 Doi: 10.15403/jgld.2014.1121.242.skp2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ludwig, H; Evstatiev, R; Kornek, G; Aapro, M; Bauernhofer, T; Buxhofer-Ausch, V; Fridrik, M; Geissler, D; Geissler, K; Gisslinger, H; Koller, E; Kopetzky, G; Lang, A; Rumpold, H; Steurer, M; Kamali, H; Link, H Iron metabolism and iron supplementation in cancer patients.
Wien Klin Wochenschr. 2015; 127(23-24):907-919 Doi: 10.1007/s00508-015-0842-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mayr, C; Neureiter, D; Wagner, A; Pichler, M; Kiesslich, T The role of polycomb repressive complexes in biliary tract cancer.
Expert Opin Ther Targets. 2015; 19(3):363-375 Doi: 10.1517/14728222.2014.986460
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Calin, GA MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients.
Br J Cancer. 2015; 113(4):569-573 Doi: 10.1038/bjc.2015.253 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Pichler, M; Haybaeck, J; Gerger, A Genetic markers of recurrence in colorectal cancer.
Pharmacogenomics. 2015; 16(11):1315-1328 Doi: 10.2217/pgs.15.83
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Gerger, A; Haybaeck, J; Kiesslich, T; Bullock, MD; Pichler, M Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future.
Anticancer Res. 2015; 35(11):5737-5744
Web of Science PubMed

 

** Thomas, J; Ohtsuka, M; Pichler, M; Ling, H MicroRNAs: Clinical Relevance in Colorectal Cancer.
Int J Mol Sci. 2015; 16(12):28063-28076 Doi: 10.3390/ijms161226080 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Editorial

** Datar, RH; Balic, M; Cote, RJ Circulating Tumor Cells: Where From Here?
Semin Oncol. 2015; 42(4):515-517 Doi: 10.1053/j.seminoncol.2015.05.010
Web of Science PubMed FullText FullText_MUG

 

Fallbericht

** Eisner, F; Pichler, M; Goletz, S; Stoeger, H; Samonigg, H A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options.
J Clin Pathol. 2015; 68(12):1044-1046 Doi: 10.1136/jclinpath-2015-202996 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Korrektur

** Ludwig, H; Evstatiev, R; Kornek, G; Aapro, M; Bauernhofer, T; Buxhofer-Ausch, V; Fridrik, M; Geissler, D; Geissler, K; Gisslinger, H; Koller, E; Kopetzky, G; Lang, A; Rumpold, H; Steurer, M; Kamali, H; Link, H Iron metabolism and iron supplementation in cancer patients (vol 127, pg 907, 2015)
WIEN KLIN WOCHENSCHR. 2015; 127(23-24): 920-921. Doi: 10.1007/s00508-015-0893-5 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** PETACC-8 study investigators; Thaler, J; Greil, R; Gaenzer, J; Eisterer, W; Tschmelitsch, J; Samonigg, H; Zabernigg, A; Schmid, F; Steger, G; Steinacher, R; Andel, J; Lang, A; Függer, R; Hofbauer, F; Woell, E; Geissler, D; Lenauer, A; Prager, M; Van Laethem, JL; Van Cutsem, E; D'Haens, G; Demolin, G; Kerger, J; Deboever, G; Ghillebert, G; Polus, M; Van Cutsem, E; RezaieKalantari, H; Delaunoit, T; Goeminne, JC; Peeters, M; Vergauwe, P; Houbiers, G; Humblet, Y; Janssens, J; Schrijvers, D; Vanderstraeten, E; Van Laethem, JL; Vermorken, J; Van Daele, D; Ferrante, M; Forget, F; Hendlisz, A; Yilmaz, M; Nielsen, SE; Vestermark, L; Larsen, J; Ychou, M; Zawadi, A; Zawadi, MA; Bouche, O; Mineur, L; Bennouna-Louridi, J; Dourthe, LM; Ychou, M; Boucher, E; Taieb, J; Pezet, D; Desseigne, F; Ducreux, M; Texereau, P; Miglianico, L; Rougier, P; Fratte, S; Levache, CB; Merrouche, Y; Ellis, S; Locher, C; Ramee, JF; Garnier, C; Viret, F; Chauffert, B; Cojean-Zelek, I; Michel, P; Lecaille, C; Borel, C; Seitz, JF; Smith, D; Lombard-Bohas, C; Andre, T; Gornet, JM; Fein, F; Coulon-Sfairi, MA; Kaminsky, MC; Lagasse, JP; Luet, D; Etienne, PL; Gasmi, M; Vanoli, A; Nguyen, S; Aparicio, T; Perrier, H; Stremsdoerfer, N; Laplaige, P; Arsene, D; Auby, D; Bedenne, L; Coriat, R; Denis, B; Geoffroy, P; Piot, G; Becouarn, Y; Bordes, G; Deplanque, G; Dupuis, O; Fruge, F; Guimbaud, R; Lecomte, T; Lledo, G; Sobhani, I; Asnacios, A; Azzedine, A; Desauw, C; Galais, MP; Gargot, D; Lam, YH; Abakar-Mahamat, A; Berdah, JF; Catteau, S; Clavero-Fabri, MC; Codoul, JF; Legoux, JL; Goldfain, D; Guichard, P; Verge, DP; Provencal, J; Vedrenne, B; Brezault-Bonnet, C; Cleau, D; Desir, JP; Fallik, D; Garcia, B; Gaspard, MH; Genet, D; Hartwig, J; Krummel, Y; MatysiakBudnik, T; Palascak-Juif, V; Randrianarivelo, H; Rinaldi, Y; Aleba, A; Darut-Jouve, A; de Gramont, A; Hamon, H; Wendehenne, F; Matzdorff, A; Stahl, MK; Schepp, W; Burk, M; Mueller, L; Folprecht, G; Geissler, M; Mantovani-Loeffler, L; Hoehler, T; Asperger, W; Kroening, H; von Weikersthal, LF; Fuxius, S; Groschek, M; Meiler, J; Trarbach, T; Rauh, J; Ziegenhagen, N; Kretzschmar, A; Graeven, U; Nusch, A; von Wichert, G; Hofheinz, RD; Kleber, G; Schmidt, KH; Vehling-Kaiser, U; Baum, C; Schuette, J; Haag, GM; Holtkamp, W; Potenberg, J; Reiber, T; Schliesser, G; Schmoll, HJ; Schneider-Kappus, W; Abenhardt, W; Denzlinger, C; Henning, J; Marxsen, B; GuenterDerigs, H; Lambertz, H; Becker-Boost, I; Caca, K; Constantin, C; Decker, T; Eschenburg, H; Gabius, S; Hebart, H; Hoffmeister, A; Horst, HA; Kremers, S; Leithaeuser, M; Mueller, S; Wagner, S; Daum, S; Schlegel, F; Stauch, M; Heinemann, V; Labianca, R; Colucci, G; Amadori, D; Mini, E; Falcone, A; Boni, C; Maiello, E; Latini, L; Zaniboni, A; Amadori, D; Aprile, G; Barni, S; Mattioli, R; Martoni, A; Passalacqua, R; Nicolini, M; Pasquini, E; Rabbi, C; Aitini, E; Ravaioli, A; Barone, C; Biasco, G; Tamberi, S; Gambi, A; Verusio, C; Marzola, M; Lelli, G; Boni, C; Cascinu, S; Bidoli, P; Vaghi, M; Cruciani, G; Di Costanzo, F; Sobrero, A; Mini, E; Petrioli, R; Aglietta, M; Alabiso, O; Capuzzo, F; Falcone, A; Corsi, DC; Labianca, R; Salvagni, S; Chiara, S; Ferraù, F; Giuliani, F; Lonardi, S; Gebbia, N; Mantovani, G; Sanches, E; Sanches, E; Mellidez, JC; Santos, P; Freire, J; Sarmento, C; Costa, L; Pinto, AM; Barroso, S; Santo, JE; Guedes, F; Monteiro, A; Sa, A; Furtado, I; Tabernero, J; Salazar, R; Aguilar, EA; Herrero, FR; Tabernero, J; Valera, JS; ValladaresAyerbes, M; FeliuBatlle, J; Gil, S; Gar ... Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Ann Oncol. 2015; 26(4):822-825 Doi: 10.1093/annonc/mdv070
PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Balic, M What is the role of resection of primary tumor in metastatic breast cancer? What is the role of cancer stem cells and circulating tumor cells and clinical state of the art
ONCOL RES TREAT. 2015; 38: 179-179.-Jahrestagung der DGHO, OeGHO, SGMO und SGH; 09.-13.10.2015; Basel. [Oral Communication]
Web of Science

 

** Benhaim, L; Zhang, W; Wakatsuki, T; Gerger, A; Yang, DY; Paez, D; Ning, Y; El-Khoueiry, RE; Loupakis, F; Bohanes, PO; Stintzing, S; Heinemann, V; Lenz, HJ Genetic variants of kinases suppressors of Ras (KSR) to predict tumor response to first-line cetuximab in patients with mCRC: Prospective analysis in the FIRE 3 trial
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL. Doi: 10.1200/jco.2015.33.15_suppl.3613 [Poster]
Web of Science FullText FullText_MUG

 

** Eisner, F; Neumeister, P; Lueger, A; Weiss, C; Krejs, GJ Pregancy-associated thrombotic thrombocytopenic purpura in a 26-year old primipara
MED KLIN-INTENSIVMED. 2015; 110(4):302-302.-47. Jahrestagung der DGIIN/ÖGIAIN; JUN 17-19, 2015; Koeln, GERMANY. [Poster]
Web of Science

 

** Gary, T; Pichler, M; Rief, P; Hafner, F; Brodmann, M The AST/ALT Ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease Patients
WIEN KLIN WOCHENSCHR. 2015; 127(17-18):721-721. [Poster]
Web of Science

 

** Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Radisic, VB; Bergh, JCS; Fitzal, F; Egle, D; Mlineritsch, B; Steger, GG; Talbot, S; Warner, DJ; Fesl, C; Singer, CF Adjuvant denosumab in breast cancer: Results from 3,425 postmenopausal patients of the ABCSG-18 trial.
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL. Doi: 10.1200/jco.2015.33.15_suppl.504 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Hatzl, S; Geiger, O; Kuepper, MK; Seime, T; Nussbaumer, E; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Jongen-Lavrencic, M; Wolfler, A; Troppmair, J; Sill, H; Zebisch, A Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a
ONCOL RES TREAT. 2015; 38: 99-99. [Oral Communication]
Web of Science

 

** Heitzer, E; Ulz, P; Auer, M; Belic, J; Sumitra, M; Lax, S; Hoefler, G; Augustin, H; Edgar, P; Bauernhofer, T; Geigl, J; Speicher, M Clinical utility of circulating tumor DNA in human cancers: A report of more than 300 plama-Seqs
EUR J CANCER. 2015; 51: S33-S33.-European Cancer Congress; Sep 25-29, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0959-8049(16)30108-3 [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, GC; Golbeck, SV; Mrsic, E; Krieger, D; Bezan, A; Jesche, J; Pummer, K; Zigeuner, R; Pichler, M Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy versus targeted agents): A European single-center experience over 26 years.
J CLIN ONCOL. 2015; 33(7):-Genitourinary Cancers Symposium; FEB 26-28, 2015; Orlando, FL. Doi: 10.1200/jco.2015.33.7_suppl.513 [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, GC; Golbeck, SV; Mrsic, E; Krieger, D; Bezan, A; Pummer, K; Zigeuner, R; Pichler, M Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy vs. targeted agents): A European single-center experience over 26 years
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL. Doi: 10.1200/jco.2015.33.15_suppl.e15617 [Poster]
Web of Science FullText FullText_MUG

 

** Issels, RD; Lindner, LH; Ghadjar, P; Reichardt, P; Hohenberger, P; Verweij, J; Abdel-Rahman, S; Daugaard, S; Salat, C; Vujaskovic, Z; Wessalowski, R; Duerr, HR; Ploner, F; Mella, O; Schmidt, M; Mansmann, U; Jauch, KW; Belka, C; Hiddemann, W; Gronchi, A Improved overall survival by adding regional hyperthermia to neo-adjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma (HR-STS): Long-term outcomes of the EORTC 62961/ESHO randomized phase III study
EUR J CANCER. . 2015; 51: S716-S716.-European Cancer Congress; 2015; Vienna, AUSTRIA. Doi: 10.1016/S0959-8049(15)30071-X [Oral Communication]
Web of Science FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Thurner, E; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T An elevated preoperative plasma fibrinogen level is related with poor prognosis in breast cancer.
BREAST. 2015; 24: S104-S104.-14th St.Gallen International Breast Cancer Conference; MAR 18-21, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0960-9776(15)70261-4 [Poster]
Web of Science FullText FullText_MUG

 

** Kump, P; Suppan, C; Spindelbock, W; Krejs, G; Lipp, R Fifty-Three Year-Old-Male with a Symptomatic Ileocecal Carcinoid: An Individual Follow-Up of 14 Yrs with 5 Different Anti-Proliferative Therapies
NEUROENDOCRINOLOGY. 2015; 102(1-2):151-151.-12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 11-13, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

** Landsmann, B; Pinter, D; Pirker, E; Wallack, E; Pichler, G; Schippinger, W; Ropele, S; Gattringer, T; Fazekas, F; Enzinger, C An exploratory intervention study suggests clinical benefits of training in chronic stroke to be paralleled by changes in brain activity using repeated fMRI
EUR J NEUROL. 2015; 22: 407-407.-1st Congress of the European-Academy-of-Neurology; June 20-23, 2015; Berlin, Germany. [Poster]
Web of Science

 

** Mayr, C; Wagner, A; Jakab, M; Illig, R; Berr, F; Pichler, M; Di Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest
ACTA PHYSIOL. 2015; 213: 148-148. [Poster]
Web of Science

 

** Mayr, C; Wagner, A; Stoecklinger, A; Jakab, M; Illig, R; Berr, F; Pichler, M; Di Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T DZNep directly targets putative cancer stem cells in biliary tract cancer cells by inhibition of polycomb repressive complex 2
ACTA PHYSIOL. 2015; 213: 147-148. [Poster]
Web of Science

 

** Merola, E; Panzuto, F; Capurso, G; Kump, P; Lipp, R; Cicchese, N; Iannicelli, E; Prosperi, D; Pizzichini, P; Rinzivillo, M; Partelli, S; Rinke, A; Falconi, M; Delle Fave, G Functional imaging tests vs. computed tomography scan: detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up
CANCER RES. 2015; 75: -106th Annual Meeting of the American-Association-for-Cancer-Research (AACR); APR 18-22, 2015; Philadelphia, PA. Doi: 10.1158/1538-7445.AM2015-3455 [Poster]
Web of Science FullText FullText_MUG

 

** Mir, O; Brodowicz, T; Wallet, J; Italiano, A; Le Cesne, A; Blay, JY; Ryckewaert, T; Bertucci, F; Piperno-Neumann, S; Ploner, F; Toulmonde, M; Domont, J; Saada, E; Delcambre, C; Isambert, N; Delaine, SC; Taieb, S; Lindner, E; Lieg-Atzwanger, B; Penel, N Activity of regorafenib (RE) in leiomyosarcomas (LMS) and other types of soft-tissue sarcomas (OTS): Results of a doubleblind, randomized placebo (PL) controlled phase II trial
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL.
Web of Science

 

** Ploner, F; Plank, J; Humer-Fuchs, U; Lax, S; Noggler, P; Rosanelli, G; Stepan, V Hypoglycaemia in a Patient with Glucagonoma-Coincidence of a Glucagonoma and Insulinoma in a Patient with Multiple Endocrine Neoplasia Type I
NEUROENDOCRINOLOGY. . 2015; 102(1-2):153-153.-12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 11-13, 2015; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

** Schmidt, S; Wolfler, A; Greil, R; Burgstaller, S; Sliwa, T; Petzer, A; Lang, A; Weltermann, A; Voskova, D; Mitterer, M; Valent, P; Eberhard, N; Walder, A; Geissler, K; Andel, J; Hausler, C; Ludescher, C; Oexle, H; Korger, M; Schnallinger, M; Schreieck, S; Krippl, P; Wiesholzer, M; Woll, E; Geissler, D; Rochau, U; Siebert, U; Thaler, J; Gastl, G Tyrosin kinase inhibitors usage and response analysis in the Austrian CML registry cohort
ONCOL RES TREAT. 2015; 38: 133-133. [Poster]
Web of Science

 

** Schwarzenbacher, D; Stiegelbauer, V; Deutsch, A; Ress, AL; Aigelsreiter, A; Schauer, S; Gerger, A; Hofler, G; Rinner, B; Pichler, M Low spinophilin expression is associated with poor prognosis and cellular growth in human breast cancer
ANN ONCOL. IMPAKT Breast Cancer Conference. 2015; 26: -IMPAKT Breast Cancer Conference; MAY 07-09, 2015; Brussels, BELGIUM. Doi: 10.1093/annonc/mdv120.6 [Poster]
Web of Science FullText FullText_MUG

 

** Schwetz, V; Eisner, F; Schilcher, G; Pieber, TR; Mader, JK; Eller, P Metformin-assoziierte Laktat- und Ketoazidose in zwei kritisch kranken Patientinnen.
Wiener Klinische Wochenschrift. 2015; 127(Suppl 4 ):S135-S136.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M Influence of immunohistological detection of intratumoral urokinase-type plasminogen activator (uPA) on disease outcome in endocrine-treated postmenopausal patients with hormone receptor-positive early breast cancer.
J CLIN ONCOL. 2015; 33(15): Doi: 10.1200/jco.2015.33.15_suppl.551 [Poster]
Web of Science FullText FullText_MUG

 

** Steger, GG; Greil, R; Hubalek, M; Fridrik, MA; Singer, CF; Bartsch, R; Balic, M; Dubsky, P; Egle, D; Gampenrieder, SP; Pfeiler, G; Mayr, D; Czech, T; Rinnerthaler, G; Exner, R; Petzer, AL; Sevelda, P; Lang, A; Rudas, M; Krause, B; Seifert, M; Frantal, S; Zielinski, CC; Gnant, M Bevacizumab in combination with docetaxel plus trastuzumab +/- non-pegylated liposomal doxorubicin: Final results of ABCSG-32, a prospective, randomized phase II-study
CANCER RES. 2015; 75(9):-37th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 09-13, 2014; San Antonio, TX.
Web of Science

 

** Troopan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, G; Beham-Schmid, C; Neumeister, P; Deutsch, A MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in aggressive non-Hodgkin's lymphoma patients
ONCOL RES TREAT. 2015; 38: 63-64. [Poster]
Web of Science

 

© Med Uni Graz Impressum